Selective serotonin reuptake inhibitor use in first trimester of pregnancy and risk of congenital anomalies: A EUROmediCAT case-malformed control study in 12 countries

---

Autoria(s): Boyle B; Loane M; Bakker M; Addor MC; Arriola L; Garne E; Gatt M; Jordan S; Khoshnood B; Klungsoyr K; Nelen V; Neville A; O'Mahony M; Pierini A; Rissmann A; Tucker D; Wiesel A; Dolk H

Data(s)	2015
Identificador	http://serval.unil.ch/?id=serval:BIB_D7A8BA0B873D
Idioma(s)	en
Fonte	International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Boston 2015
Tipo	info:eu-repo/semantics/conferenceObject inproceedings